SOHM Announces Business Outlook for 2024

Stock Information for Sohm Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sohm Inc

SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery
Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization
SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology
SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies
SOHM, Inc. Announces Patent Allowance/Approval in South Korea
SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE
SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations
SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.